Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FRMD4A |
| Upstream (Parents) |
|---|
| (<<) PMS2L3 → FRMD4A |
| (<<) HERC4 → FRMD4A |
| (<<) OASL → FRMD4A |
| (<<) C3orf75 → FRMD4A |
| (<<) ATXN7L1 → FRMD4A |
| (<<) TAOK1 → FRMD4A |
| (<<) SPTLC3 → FRMD4A |
| Downstream (Children) |
|---|
| FRMD4A → PMS2L3 (>>) |
| FRMD4A → ERAP2 (>>) |
| FRMD4A → LHCGR (>>) |
| FRMD4A → DCC (>>) |
| FRMD4A → C3orf75 (>>) |
| FRMD4A → CRYBA2 (>>) |
| FRMD4A → GGTLC2 (>>) |
| FRMD4A → SPANXC (>>) |
| FRMD4A → SPTLC3 (>>) |
| FRMD4A → TNPO2 (>>) |
